DR
XYL icon

Davis Rea’s Xylem XYL Stock Holding History

Davis Rea’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Buy
34,415
+1,825
+6% +$211K 1.16% 27
2026
Q1 		$3.89M Buy
32,590
+2,350
+8% +$308K 1.02% 36
2025
Q4 		$4.12M Sell
30,240
-27
-0.1% -$3.88K 1.03% 34
2025
Q3 		$4.46M Sell
30,267
-430
-1% -$59.6K 1.08% 34
2025
Q2 		$3.97M Buy
30,697
+278
+0.9% +$33.7K 0.99% 35
2025
Q1 		$3.63M Buy
+30,419
New +$3.77M 0.97% 36

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Davis Rea's XYL Position: Q2 2026 in Review

Davis Rea increased its Xylem (XYL) stake by 5.6% in Q2 2026, buying an estimated $211K and bringing the position to 34,415 shares worth $4.07M. The position accounts for 1.16% of the portfolio, ranked #27.

Davis Rea first reported a position in XYL in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.46M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Davis Rea held 34,415 shares of Xylem worth $4.07M as of Q2 2026.
  • Davis Rea bought 1,825 Xylem shares in Q2 2026, an estimated $211K.
  • Xylem made up 1.16% of Davis Rea's portfolio in Q2 2026, its #27 holding.
  • Davis Rea first reported a position in Xylem in Q1 2025 and has held it in 6 quarters since.
  • Davis Rea's Xylem position peaked at $4.46M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Davis Rea's 13F filing for Q2 2026, filed 4 Aug 2026.